Atlas Trials

Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients

Clinical trial NCT02039518 · UNKNOWN

Trial details

NCT number
NCT02039518
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2013-12-01
Primary completion
2017-06-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.